Market research
LIFE Ethos Technologies Inc. Class A Common Stock
NASDAQ USD Financial Services
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3B
- P/E ratio
- Not available
- Analyst target
- 34.875
- Dividend yield
- Not available
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the LIFE discussion.
5 years, 4 months ago
aTyr Pharma, Inc is currently in a long term uptrend where the price is trading 12.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
aTyr Pharma, Inc's total revenue sank by 92.7% to $10K since the same quarter in the previous year.
Its net income has increased by 17.4% to $-5M since the same quarter in the previous year.
Finally, its free cash flow fell by 9.1% to $-5M since the same quarter in the previous year.
Based on the above factors, aTyr Pharma, Inc gets an overall score of 3/5.